Changes in bone turnover markers and bone modulators during abatacept treatment

Changes in bone turnover markers and bone modulators during abatacept treatment

Abstract Rheumatoid arthritis (RA) causes bone loss, only partly related to inflammation. The impact of RA treatments on bone metabolism and their ability to mitigate bone loss remains uncertain. The primary goal of our study was to examine the influence of abatacept on serum levels of markers and r...

Full description

Bibliographic Details
Main Authors: Giovanni Adami, Giovanni Orsolini, Maurizio Rossini, Elisa Pedrollo, Anna Fratucello, Angelo Fassio, Ombretta Viapiana, Stefano Milleri, Elena Fracassi, Riccardo Bixio, Davide Gatti
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-44374-2

Similar Items

Similar Items